The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 680-686 , June 2010

Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation

  • Elisabeth A. Kastelijn, MD

      Affiliations

    • Centre of Interstitial Lung Diseases, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Coline H. van Moorsel, PhD

      Affiliations

    • Centre of Interstitial Lung Diseases, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Henk J. Ruven, PhD

      Affiliations

    • Department of Clinical Chemistry, St Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Vincent Karthaus, MSc

      Affiliations

    • Centre of Interstitial Lung Diseases, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Johanna M. Kwakkel-van Erp, MD

      Affiliations

    • Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • Ed A. van de Graaf, MD, PhD

      Affiliations

    • Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • Pieter Zanen, MD

      Affiliations

    • Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • Diana A. van Kessel, MD

      Affiliations

    • Centre of Interstitial Lung Diseases, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Jan C. Grutters, MD, PhD

      Affiliations

    • Centre of Interstitial Lung Diseases, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
    • Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationReprint requests: J.C. Grutters, MD, PhD, St. Antonius Hospital, Postbox 2500, 3420 EM Nieuwegein, The Netherlands. Telephone: +31-0-30-609-2428. Fax: +31-0-30-605-2001
    • ,
  • Jules M. van den Bosch, MD, PhD

      Affiliations

    • Centre of Interstitial Lung Diseases, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
    • Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands

References 

  1. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21:297–310
  2. Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest. 1998;114:1411–1426
  3. Grossman EJ, Shilling RA. Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future. Transl Res. 2009;153:153–165
  4. Ikonen TS, Brazelton TR, Berry GJ, Shorthouse RS, Morris RE. Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats. Transplantation. 2000;70:857–863
  5. Fernandez FG, Jaramillo A, Chen C, et al. Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant. 2004;4:319–325
  6. Kuo E, Bharat A, Shih J, et al. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection. Ann Thorac Surg. 2006;82:1226–1233
  7. Parks WC. Matrix metalloproteinases in lung repair. Eur Respir J Suppl. 2003;44:36s–38s
  8. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res. 2001;2:10–19
  9. Dunsmore SE, Saarialho-Kere UK, Roby JD, et al. Matrilysin expression and function in airway epithelium. J Clin Invest. 1998;102:1321–1331
  10. Parks WC, Lopez-Boado YS, Wilson CL. Matrilysin in epithelial repair and defense. Chest. 2001;120(1 suppl):36S–41S
  11. Chen P, McGuire JK, Hackman RC, et al. Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity. Am J Pathol. 2008;172:1256–1270
  12. Hubner RH, Meffert S, Mundt U, et al. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J. 2005;25:494–501
  13. Taghavi S, Krenn K, Jaksch P, Klepetko W, Aharinejad S. Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans. Am J Transplant. 2005;5:1548–1552
  14. Smith GN, Mickler EA, Payne KK, et al. Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome. Am J Transplant. 2007;7:1856–1861
  15. Pardo A, Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc. 2006;3:383–388
  16. McKeown S, Richter AG, O'Kane C, McAuley DF, Thickett DR. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J. 2009;33:77–84
  17. Rosas IO, Richards TJ, Konishi K, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008;5:e93
  18. Lievre A, Milet J, Carayol J, et al. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer. 2006;6:270
  19. Hughes S, Agbaje O, Bowen RL, et al. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin Cancer Res. 2007;13:6673–6680
  20. Kitamura T, Biyajima K, Aoki M, Oshima M, Taketo MM. Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas. Lab Invest. 2009;89:98–105
  21. Acar A, Onan A, Coskun U, et al. Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer. Med Oncol. 2008;25:279–283
  22. Murphy G, Cockett MI, Ward RV, Docherty AJ. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan (A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)). Biochem J. 1991;277:277–279
  23. Busiek DF, Baragi V, Nehring LC, Parks WC, Welgus HG. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol. 1995;154:6484–6491
  24. Busiek DF, Ross FP, McDonnell S, Murphy G, Matrisian LM, Welgus HG. The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J Biol Chem. 1992;267:9087–9092
  25. Chen P, Abacherli LE, Nadler ST, Wang Y, Li Q, Parks WC. MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation. PLoS One. 2009;4:e6565
  26. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003;253:269–285
  27. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217–1223
  28. Bharat A, Fields RC, Steward N, Trulock EP, Patterson GA, Mohanakumar T. CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant. 2006;6:1799–1808
  29. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity. 2005;95:221–227
  30. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 2005;76:449–462
  31. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  32. Maurel J, Nadal C, Garcia-Albeniz X, et al. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer. 2007;121:1066–1071
  33. Ribeiro CM, Hurd H, Wu Y, et al. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PLoS One. 2009;4:e5806
  34. Beeghly-Fadiel A, Shu XO, Long J, et al. Genetic polymorphisms in the MMP-7 gene and breast cancer survival. Int J Cancer. 2009;124:208–214
  35. Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2001;21:1834–1839

PII: S1053-2498(10)00040-9

doi: 10.1016/j.healun.2010.01.008

The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 680-686 , June 2010

Article Tools

* Image Usage & Resolution